About Hemosphere
Hemosphere is a company based in Eden Prairie (United States) founded in 1987 was acquired by CryoLife in May 2012. Hemosphere has raised $9.3 million across 1 funding round from investors including Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management. Hemosphere offers products and services including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters. Hemosphere operates in a competitive market with competitors including TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
- Headquarter Eden Prairie, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hemosphere, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.3 M (USD)
in 1 rounds
-
Latest Funding Round
$9.3 M (USD), Series A
Mar 31, 2010
-
Investors
Kaiser Permanente Ventures
& 7 more
-
Employee Count
Not available
-
Acquired by
CryoLife
(May 15, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemosphere
Hemosphere offers a comprehensive portfolio of products and services, including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters.
Provides subcutaneous access for hemodialysis to reduce infections.
Expands HeRO Graft functionality for improved vascular access.
Facilitates access in patients with venous occlusive disease.
Offers long-term access with self-centering tips for efficiency.
Funding Insights of Hemosphere
Hemosphere has successfully raised a total of $9.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.3 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Hemosphere
Hemosphere has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in companies in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Hemosphere
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hemosphere
Investment portfolio details for Hemosphere
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hemosphere
Detailed financials for Hemosphere
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemosphere Comparisons
Peer comparison for Hemosphere
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hemosphere
Hemosphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
Detailed competitors of Hemosphere
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemosphere
Complete news archive for Hemosphere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemosphere
Hemosphere was founded in 1987 and raised its 1st funding round 23 years after it was founded.
Hemosphere is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Hemosphere is a funded company, having raised a total of $9.3M across 1 funding round to date.
Hemosphere was founded in 1987 as a medical device company focused on vascular access solutions. Operations center on the development and commercialization of the Hemodialysis Reliable Outflow (HeRO) Graft, designed for patients with failing fistulas, grafts, or catheter dependency due to venous blockages. The company, previously known as GRAFTcath, Inc., rebranded in 2008 and is based in Eden Prairie, United States, serving the hemodialysis sector.
Hemosphere's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Hemosphere offers HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters.
Hemosphere has 8 investors. Key investors include Kaiser Permanente Ventures, Three Arch Partners, Affinity Capital Management, Sapient Capital Partners, and Cutlass Capital.